GLS loss or GLS-specific inhibitor bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) attenuates tumor progression and prolonged survival in Myc-driven HCC mouse model (Xiang et al., 2015). This evidence concerns the gene GLS and hepatocellular carcinoma.